Esjay Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ESJAY PHARMA
ESJAY PHARMA has six approved drugs.
Summary for Esjay Pharma
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for Esjay Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esjay Pharma | ROCALTROL | calcitriol | SOLUTION;ORAL | 021068-001 | Nov 20, 1998 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Esjay Pharma | FUROSEMIDE | furosemide | TABLET;ORAL | 018415-003 | Nov 26, 1984 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Esjay Pharma | FUROSEMIDE | furosemide | TABLET;ORAL | 018415-002 | Jul 27, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Esjay Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Esjay Pharma | PARLODEL | bromocriptine mesylate | TABLET;ORAL | 017962-001 | Approved Prior to Jan 1, 1982 | 3,752,888 | ⤷ Start Trial |
| Esjay Pharma | ROCALTROL | calcitriol | CAPSULE;ORAL | 018044-001 | Approved Prior to Jan 1, 1982 | 4,391,802 | ⤷ Start Trial |
| Esjay Pharma | PARLODEL | bromocriptine mesylate | CAPSULE;ORAL | 017962-002 | Mar 1, 1982 | 3,752,814 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
